There was some earlier conjecture on the size of the market and...

There was some earlier conjecture on the size of the market and potential annual future sales for ReCell re: interview with Bill Dolphin. Re-listening to the interview, Dolphin discusses the different market segments which ReCell is targeting - chronic wounds, burns and cosmetic applications e.g. wrinkles, acne scarring.

"We can see that, on the order of 10-12 million procedures will be done per year utilising ReCell," said Dolphin.

The number of ReCell kits which Dolphin can visualize being sold is 10-12 million annually. Assuming a sales value per kit of $750, Dolphin is projecting a future turnover of $7.5B. Of course the future could be 5-15 years away. The sheer scale of the market and the revolutionary impact of the ReCell procedure will - at some point in time - make Avita Medical a hotly contested takeover target. Of course, as Dolphin appears to suggest in the interview - that's the whole point.